Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USA

OBJECTIVES: Prostate cancer mortality (PCM) in the USA is among the lowest in the world, whereas PCM in England is among the highest in Europe. This paper aims to assess the association of variation in use of definitive therapy on risk-adjusted PCM in England as compared with the USA. DESIGN: Observ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachdeva, Ashwin, van der Meulen, Jan H, Emberton, Mark, Cathcart, Paul J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342590/
https://www.ncbi.nlm.nih.gov/pubmed/25712821
http://dx.doi.org/10.1136/bmjopen-2014-006805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342590/
https://www.ncbi.nlm.nih.gov/pubmed/25712821
http://dx.doi.org/10.1136/bmjopen-2014-006805

Ejemplares similares